AIDS 2016 Menan Gérard Kouamé presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.comHBV and HIVOngoing HBV replication associated with higher mortality for people with HIV. Jürgen Rockstroh presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.comHCV and HIVAbbVie 3D and 2D HCV combos work well for people with HIV co-infection. Norbert Bräu presenting at AIDS 2016. Photo by Liz Highleyman, hivandhepatitis.comHCV and HIVSofosbuvir/velpatasvir shows high cure rate in HIV/HCV co-infection study. infohep news HIV and HBV Ongoing hepatitis B virus replication associated with higher mortality for people with HIV Liz Highleyman / 11 August 2016 People with HIV and hepatitis B virus (HBV) co-infection have more than double the risk of death if they have ongoing high-level HBV replication, indicating a need for prompt treatment, according to an ... Treatment for people living with HIV and HCV AbbVie 3D and 2D hepatitis C combos work well for people with HIV and HCV co-infection Liz Highleyman / 01 August 2016 AbbVie's paritaprevir-based 3D regimen for hepatitis C virus (HCV) genotype 1 and 2D regimen for genotype 4 were shown to be highly effective and well tolerated for HIV-positive people with HCV co-infection ... Treatment for people living with HIV and HCV Sofosbuvir/velpatasvir shows high cure rate in HIV/HCV co-infection study Liz Highleyman / 21 July 2016 The once-daily co-formulation of sofosbuvir and velpatasvir was highly effective against all hepatitis C virus (HCV) genotypes in people with HIV/HCV co-infection and was safe and well tolerated in the ASTRAL-5 trial, according ... View more > Editors' picks from other sources View more > Other pages in this section Latest news All the news Conference news Email bulletin archive